AVEO Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €33.28M +545.9% -€52.37M +71.9% -157.4% +4.3 pp -€49.02M +52.2% -147.3% +4.8 pp
    €5.15M -79.1% -€30.46M -479.0% -591.2% -6.2 pp -€32.21M +1,188.8% -625.0% -6.1 pp
    €24.65M +432.4% €8.04M -276.2% 32.6% +1.3 pp -€2.50M -88.3% -10.1% +4.5 pp
    €4.63M -28.6% -€4.56M -91.8% -98.5% +7.6 pp -€21.42M +30.6% -462.7% -2.1 pp
    €6.49M +201.4% -€55.67M +141.8% -858.0% +2.1 pp -€16.41M -38.3% -252.9% +9.8 pp
    €2.15M -86.8% -€23.02M +79.2% -1,069.1% -9.9 pp -€26.59M +70.6% -1,235.0% -11 pp
    €16.29M +5.0% -€12.84M -71.6% -78.9% +2.1 pp -€15.59M -55.9% -95.7% +1.3 pp
    €15.51M +1,301.6% -€45.15M -50.7% -291.0% +80 pp -€35.36M -48.8% -227.9% +60 pp
    €1.11M -93.3% -€91.63M -6.4% -8,277.6% -77 pp -€69.12M -15.7% -6,243.9% -57 pp
    €16.51M -88.3% -€97.93M -473.3% -593.1% -6.1 pp -€82.00M -429.4% -496.6% -5.1 pp
    €141.13M +268.9% €26.24M -152.1% 18.6% +1.5 pp €24.89M -158.0% 17.6% +1.3 pp
    €38.25M +115.7% -€50.33M +33.3% -131.6% +0.81 pp -€42.92M +508.5% -112.2% -0.72 pp
    €17.74M +5.4% -€37.75M +35.8% -212.8% -0.48 pp -€7.05M -75.7% -39.8% +1.3 pp
    €16.83M +78.2% -€27.80M +30.0% -165.2% +0.61 pp -€29.06M +312.5% -172.7% -0.98 pp
    €9.45M -€21.39M -226.4% -€7.04M -74.6%

    Notifications